Immunogenomics Market Size, Share & Trends Analysis Report By Type, By Technology, By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED: March 2, 2026

PAGES: 120 Pages

DELIVERY TIME: 2-10 business days

ADD TO COMPARE

SELECT AN OPTION

The global immunogenomics market size was estimated at USD 6.32 billion in 2025 and is projected to reach USD 9.82 billion by 2033, expanding at a CAGR of 5.97% from 2026 to 2033. The market growth is being driven by advancements in next-generation sequencing technologies, increasing demand for personalized medicine, and the rising prevalence of immune-related disorders.

Global Immunogenomics Market report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the immunogenomics market on the basis of product type, technology, application, end user, and region.

Product Type Outlook (Revenue, USD Million, 2021 - 2033)
Instruments
Consumables
Software
Technology Outlook (Revenue, USD Million, 2021 - 2033)
Next-Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Microarray
Other Technologies
Application Outlook (Revenue, USD Million, 2021 - 2033)
Clinical Applications
- Oncology / Cancer Immunotherapy
- Infectious Diseases & Vaccine Research
- Autoimmune Disorders
- Others
Research Applications
End User Outlook (Revenue, USD Million, 2021 - 2033)
Hospitals & Diagnostic Laboratories
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Other End Users
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
Latin America
- Brazil
- Argentina
Middle East and Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Product Code: GVR-4-68040-869-1

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
- 1.2.1. Product type
- 1.2.2. Technology
- 1.2.3. Application
- 1.2.4. End Use
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
- 1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
  - 3.2.1.1. Advancements in next-generation sequencing (NGS) and bioinformatics
  - 3.2.1.2. Growing prevalence of immune-related disorders
- 3.2.2. Market Restraint Analysis
  - 3.2.2.1. Data complexity and interpretation
  - 3.2.2.2. Stringent regulatory requirements
- 3.2.3. Market Opportunity Analysis
- 3.2.4. Market Challenge Analysis
3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis

Chapter 4. Immunogenomics Market: Product Type Business Analysis

4.1. Product Type Segment Dashboard
4.2. Global Immunogenomics Market Product Type Movement Analysis
4.3. Global Immunogenomics Market Size & Trend Analysis, by Product Type, 2021 to 2033 (USD Million)
4.4. Instruments
- 4.4.1. Global Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Consumables
- 4.5.1. Global Consumables Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Software
- 4.6.1. Global Software Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Immunogenomics Market: Technology Business Analysis

5.1. Technology Segment Dashboard
5.2. Global Immunogenomics Market Technology Movement Analysis
5.3. Global Immunogenomics Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
5.4. Next-Generation Sequencing (NGS)
- 5.4.1. Global Next-Generation Sequencing (NGS) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Polymerase Chain Reaction (PCR)
- 5.5.1. Global Polymerase Chain Reaction (PCR) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Microarray
- 5.6.1. Global Microarray Market Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Other Technologies
- 5.7.1. Global Other Technologies Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Immunogenomics Market: Application Business Analysis

6.1. Application Segment Dashboard
6.2. Global Immunogenomics Market Application, Movement Analysis
6.3. Global Immunogenomics Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Clinical Applications
- 6.4.1. Global Clinical Applications Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4.2. Oncology / Cancer Immunotherapy
  - 6.4.2.1. Global Oncology / Cancer Immunotherapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4.3. Infectious diseases & vaccine research
  - 6.4.3.1. Global Infectious Diseases & Vaccine Research Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4.4. Autoimmune Disorders
  - 6.4.4.1. Global Autoimmune Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4.5. Others
  - 6.4.5.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Research Applications
- 6.5.1. Global Research Applications Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Immunogenomics Market: End User Business Analysis

7.1. End User Segment Dashboard
7.2. Global Immunogenomics Market End User Movement Analysis
7.3. Global Immunogenomics Market Size & Trend Analysis, by End User, 2021 to 2033 (USD Million)
7.4. Hospitals & Diagnostic Laboratories
- 7.4.1. Global Hospitals & Diagnostic Laboratories Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. Academic & Research Institutes
- 7.5.1. Global Academic & Research Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. Pharmaceutical & Biotechnology Companies
- 7.6.1. Global Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7. Other End Users
- 7.7.1. Global Other End Users Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Immunogenomics Market: Regional Estimates & Trend Analysis by Product Type, Technology, Application, & End User.

8.1. Regional Dashboard
8.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
8.3. North America
- 8.3.1. North America Immunogenomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.3.2. U.S.
  - 8.3.2.1. Key Country Dynamics
  - 8.3.2.2. Competitive Scenario
  - 8.3.2.3. Regulatory Framework
  - 8.3.2.4. U.S. Immunogenomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.3.3. Canada
  - 8.3.3.1. Key Country Dynamics
  - 8.3.3.2. Competitive Scenario
  - 8.3.3.3. Regulatory Framework
  - 8.3.3.4. Canada Immunogenomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.3.4. Mexico
  - 8.3.4.1. Key Country Dynamics
  - 8.3.4.2. Competitive Scenario
  - 8.3.4.3. Regulatory Framework
  - 8.3.4.4. Mexico Immunogenomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4. Europe
- 8.4.1. Europe Immunogenomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.2. UK
  - 8.4.2.1. Key Country Dynamics
  - 8.4.2.2. Competitive Scenario
  - 8.4.2.3. Regulatory Framework
  - 8.4.2.4. UK Immunogenomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.3. Germany
  - 8.4.3.1. Key Country Dynamics
  - 8.4.3.2. Competitive Scenario
  - 8.4.3.3. Regulatory Framework
  - 8.4.3.4. Germany Immunogenomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.4. France
  - 8.4.4.1. Key Country Dynamics
  - 8.4.4.2. Competitive Scenario
  - 8.4.4.3. Regulatory Framework
  - 8.4.4.4. France Immunogenomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.5. Italy
  - 8.4.5.1. Key Country Dynamics
  - 8.4.5.2. Competitive Scenario
  - 8.4.5.3. Regulatory Framework
  - 8.4.5.4. Italy Immunogenomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.6. Spain
  - 8.4.6.1. Key Country Dynamics
  - 8.4.6.2. Competitive Scenario
  - 8.4.6.3. Regulatory Framework
  - 8.4.6.4. Spain Immunogenomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.7. Denmark
  - 8.4.7.1. Key Country Dynamics
  - 8.4.7.2. Competitive Scenario
  - 8.4.7.3. Regulatory Framework
  - 8.4.7.4. Denmark Immunogenomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.8. Sweden
  - 8.4.8.1. Key Country Dynamics
  - 8.4.8.2. Competitive Scenario
  - 8.4.8.3. Regulatory Framework
  - 8.4.8.4. Sweden Immunogenomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.9. Norway
  - 8.4.9.1. Key Country Dynamics
  - 8.4.9.2. Competitive Scenario
  - 8.4.9.3. Regulatory Framework
  - 8.4.9.4. Norway Immunogenomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5. Asia Pacific
- 8.5.1. Asia Pacific Immunogenomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.2. Japan
  - 8.5.2.1. Key Country Dynamics
  - 8.5.2.2. Competitive Scenario
  - 8.5.2.3. Regulatory Framework
  - 8.5.2.4. Japan Immunogenomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.3. China
  - 8.5.3.1. Key Country Dynamics
  - 8.5.3.2. Competitive Scenario
  - 8.5.3.3. Regulatory Framework
  - 8.5.3.4. China Immunogenomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.4. India
  - 8.5.4.1. Key Country Dynamics
  - 8.5.4.2. Competitive Scenario
  - 8.5.4.3. Regulatory Framework
  - 8.5.4.4. India Immunogenomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.5. Australia
  - 8.5.5.1. Key Country Dynamics
  - 8.5.5.2. Competitive Scenario
  - 8.5.5.3. Regulatory Framework
  - 8.5.5.4. Australia Immunogenomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.6. Thailand
  - 8.5.6.1. Key Country Dynamics
  - 8.5.6.2. Competitive Scenario
  - 8.5.6.3. Regulatory Framework
  - 8.5.6.4. Thailand Immunogenomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.7. South Korea
  - 8.5.7.1. Key Country Dynamics
  - 8.5.7.2. Competitive Scenario
  - 8.5.7.3. Regulatory Framework
  - 8.5.7.4. South Korea Immunogenomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6. Latin America
- 8.6.1. Latin America Immunogenomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6.2. Brazil
  - 8.6.2.1. Key Country Dynamics
  - 8.6.2.2. Competitive Scenario
  - 8.6.2.3. Regulatory Framework
  - 8.6.2.4. Brazil Immunogenomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6.3. Argentina
  - 8.6.3.1. Key Country Dynamics
  - 8.6.3.2. Competitive Scenario
  - 8.6.3.3. Regulatory Framework
  - 8.6.3.4. Argentina Immunogenomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.7. MEA
- 8.7.1. MEA Immunogenomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.7.2. South Africa
  - 8.7.2.1. Key Country Dynamics
  - 8.7.2.2. Competitive Scenario
  - 8.7.2.3. Regulatory Framework
  - 8.7.2.4. South Africa Immunogenomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.7.3. Saudi Arabia
  - 8.7.3.1. Key Country Dynamics
  - 8.7.3.2. Competitive Scenario
  - 8.7.3.3. Regulatory Framework
  - 8.7.3.4. Saudi Arabia Immunogenomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.7.4. UAE
  - 8.7.4.1. Key Country Dynamics
  - 8.7.4.2. Competitive Scenario
  - 8.7.4.3. Regulatory Framework
  - 8.7.4.4. UAE Immunogenomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.7.5. Kuwait
  - 8.7.5.1. Key Country Dynamics
  - 8.7.5.2. Competitive Scenario
  - 8.7.5.3. Regulatory Framework
  - 8.7.5.4. Kuwait Immunogenomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

9.1. Participant Categorization
9.2. Strategy Mapping
9.3. Company Market Share/ Position Analysis, 2025
9.4. Participant's Overview
- 9.4.1. Thermo Fisher Scientific
  - 9.4.1.1. Overview
  - 9.4.1.2. Financial Performance
  - 9.4.1.3. Product Benchmarking
  - 9.4.1.4. Strategic Initiatives
- 9.4.2. Illumina, Inc.
  - 9.4.2.1. Overview
  - 9.4.2.2. Financial Performance
  - 9.4.2.3. Product Benchmarking
  - 9.4.2.4. Strategic Initiatives
- 9.4.3. QIAGEN N.V.
  - 9.4.3.1. Overview
  - 9.4.3.2. Financial Performance
  - 9.4.3.3. Product Benchmarking
  - 9.4.3.4. Strategic Initiatives
- 9.4.4. F. Hoffmann-La Roche Ltd
  - 9.4.4.1. Overview
  - 9.4.4.2. Financial Performance
  - 9.4.4.3. Product Benchmarking
  - 9.4.4.4. Strategic Initiatives
- 9.4.5. Agilent Technologies, Inc.
  - 9.4.5.1. Overview
  - 9.4.5.2. Financial Performance
  - 9.4.5.3. Product Benchmarking
  - 9.4.5.4. Strategic Initiatives
- 9.4.6. Bio-Rad Laboratories, Inc.
  - 9.4.6.1. Overview
  - 9.4.6.2. Financial Performance
  - 9.4.6.3. Product Benchmarking
  - 9.4.6.4. Strategic Initiatives
- 9.4.7. Pacific Biosciences of California, Inc.
  - 9.4.7.1. Overview
  - 9.4.7.2. Financial Performance
  - 9.4.7.3. Product Benchmarking
  - 9.4.7.4. Strategic Initiatives
- 9.4.8. Oxford Nanopore Technologies plc
  - 9.4.8.1. Overview
  - 9.4.8.2. Financial Performance
  - 9.4.8.3. Product Benchmarking
  - 9.4.8.4. Strategic Initiatives
- 9.4.9. Eurofins Scientific SE
  - 9.4.9.1. Overview
  - 9.4.9.2. Financial Performance
  - 9.4.9.3. Product Benchmarking
  - 9.4.9.4. Strategic Initiatives
- 9.4.10. CareDx, Inc.
  - 9.4.10.1. Overview
  - 9.4.10.2. Financial Performance
  - 9.4.10.3. Product Benchmarking
  - 9.4.10.4. Strategic Initiatives

Product Code: GVR-4-68040-869-1

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global immunogenomics market, by product type, 2021 - 2033 (USD million)
Table 4 Global immunogenomics market, by technology, 2021 - 2033 (USD million)
Table 5 Global immunogenomics market, by application, 2021 - 2033 (USD million)
Table 6 Global immunogenomics market, by end user, 2021 - 2033 (USD million)
Table 7 Global immunogenomics market, by region, 2021 - 2033 (USD million)
Table 8 North America immunogenomics market, by country, 2021 - 2033 (USD million)
Table 9 North America immunogenomics market, by technology, 2021 - 2033 (USD million)
Table 10 North America immunogenomics market, by product type, 2021 - 2033 (USD million)
Table 11 North America immunogenomics market, by application, 2021 - 2033 (USD million)
Table 12 North America immunogenomics market, by end user, 2021 - 2033 (USD million)
Table 13 U.S. immunogenomics market, by product type, 2021 - 2033 (USD million)
Table 14 U.S. immunogenomics market, by technology, 2021 - 2033 (USD million)
Table 15 U.S. immunogenomics market, by application, 2021 - 2033 (USD million)
Table 16 U.S. immunogenomics market, by end user, 2021 - 2033 (USD million)
Table 17 Canada immunogenomics market, by product type, 2021 - 2033 (USD million)
Table 18 Canada immunogenomics market, by technology, 2021 - 2033 (USD million)
Table 19 Canada immunogenomics market, by application, 2021 - 2033 (USD million)
Table 20 Canada immunogenomics market, by end user, 2021 - 2033 (USD million)
Table 21 Mexico immunogenomics market, by product type, 2021 - 2033 (USD million)
Table 22 Mexico immunogenomics market, by technology, 2021 - 2033 (USD million)
Table 23 Mexico immunogenomics market, by application, 2021 - 2033 (USD million)
Table 24 Mexico immunogenomics market, by end user, 2021 - 2033 (USD million)
Table 25 Europe immunogenomics market, by country, 2021 - 2033 (USD million)
Table 26 Europe immunogenomics market, by product type, 2021 - 2033 (USD million)
Table 27 Europe immunogenomics market, by technology, 2021 - 2033 (USD million)
Table 28 Europe immunogenomics market, by application, 2021 - 2033 (USD million)
Table 29 Europe immunogenomics market, by end user, 2021 - 2033 (USD million)
Table 30 UK immunogenomics market, by product type, 2021 - 2033 (USD million)
Table 31 UK immunogenomics market, by technology, 2021 - 2033 (USD million)
Table 32 UK immunogenomics market, by application, 2021 - 2033 (USD million)
Table 33 UK immunogenomics market, by end user, 2021 - 2033 (USD million)
Table 34 Germany immunogenomics market, by product type, 2021 - 2033 (USD million)
Table 35 Germany immunogenomics market, by technology, 2021 - 2033 (USD million)
Table 36 Germany immunogenomics market, by application, 2021 - 2033 (USD million)
Table 37 Germany immunogenomics market, by end user, 2021 - 2033 (USD million)
Table 38 France immunogenomics market, by product type, 2021 - 2033 (USD million)
Table 39 France immunogenomics market, by technology, 2021 - 2033 (USD million)
Table 40 France immunogenomics market, by application, 2021 - 2033 (USD million)
Table 41 France immunogenomics market, by end user, 2021 - 2033 (USD million)
Table 42 Italy immunogenomics market, by product type, 2021 - 2033 (USD million)
Table 43 Italy immunogenomics market, by technology, 2021 - 2033 (USD million)
Table 44 Italy immunogenomics market, by application, 2021 - 2033 (USD million)
Table 45 Italy immunogenomics market, by end user, 2021 - 2033 (USD million)
Table 46 Spain immunogenomics market, by product type, 2021 - 2033 (USD million)
Table 47 Spain immunogenomics market, by technology, 2021 - 2033 (USD million)
Table 48 Spain immunogenomics market, by application, 2021 - 2033 (USD million)
Table 49 Spain immunogenomics market, by end user, 2021 - 2033 (USD million)
Table 50 Denmark immunogenomics market, by product type, 2021 - 2033 (USD million)
Table 51 Denmark immunogenomics market, by technology, 2021 - 2033 (USD million)
Table 52 Denmark immunogenomics market, by application, 2021 - 2033 (USD million)
Table 53 Denmark immunogenomics market, by end user, 2021 - 2033 (USD million)
Table 54 Sweden immunogenomics market, by product type, 2021 - 2033 (USD million)
Table 55 Sweden immunogenomics market, by technology, 2021 - 2033 (USD million)
Table 56 Sweden immunogenomics market, by application, 2021 - 2033 (USD million)
Table 57 Sweden immunogenomics market, by end user, 2021 - 2033 (USD million)
Table 58 Norway immunogenomics market, by product type, 2021 - 2033 (USD million)
Table 59 Norway immunogenomics market, by technology, 2021 - 2033 (USD million)
Table 60 Norway immunogenomics market, by application, 2021 - 2033 (USD million)
Table 61 Norway immunogenomics market, by end user, 2021 - 2033 (USD million)
Table 62 Asia Pacific immunogenomics market, by country, 2021 - 2033 (USD million)
Table 63 Asia Pacific immunogenomics market, by product type, 2021 - 2033 (USD million)
Table 64 Asia Pacific immunogenomics market, by technology, 2021 - 2033 (USD million)
Table 65 Asia Pacific immunogenomics market, by application, 2021 - 2033 (USD million)
Table 66 Asia Pacific immunogenomics market, by end user, 2021 - 2033 (USD million)
Table 67 Japan immunogenomics market, by product type, 2021 - 2033 (USD million)
Table 68 Japan immunogenomics market, by technology, 2021 - 2033 (USD million)
Table 69 Japan immunogenomics market, by application, 2021 - 2033 (USD million)
Table 70 Japan immunogenomics market, by end user, 2021 - 2033 (USD million)
Table 71 China immunogenomics market, by product type, 2021 - 2033 (USD million)
Table 72 China immunogenomics market, by technology, 2021 - 2033 (USD million)
Table 73 China immunogenomics market, by application, 2021 - 2033 (USD million)
Table 74 China immunogenomics market, by end user, 2021 - 2033 (USD million)
Table 75 India immunogenomics market, by product type, 2021 - 2033 (USD million)
Table 76 India immunogenomics market, by technology, 2021 - 2033 (USD million)
Table 77 India immunogenomics market, by application, 2021 - 2033 (USD million)
Table 78 India immunogenomics market, by end user, 2021 - 2033 (USD million)
Table 79 Australia immunogenomics market, by product type, 2021 - 2033 (USD million)
Table 80 Australia immunogenomics market, by technology, 2021 - 2033 (USD million)
Table 81 Australia immunogenomics market, by application, 2021 - 2033 (USD million)
Table 82 Australia immunogenomics market, by end user, 2021 - 2033 (USD million)
Table 83 Thailand immunogenomics market, by product type, 2021 - 2033 (USD million)
Table 84 Thailand immunogenomics market, by technology, 2021 - 2033 (USD million)
Table 85 Thailand immunogenomics market, by application, 2021 - 2033 (USD million)
Table 86 Thailand immunogenomics market, by end user, 2021 - 2033 (USD million)
Table 87 South Korea immunogenomics market, by product type, 2021 - 2033 (USD million)
Table 88 South Korea immunogenomics market, by technology, 2021 - 2033 (USD million)
Table 89 South Korea immunogenomics market, by application, 2021 - 2033 (USD million)
Table 90 South Korea immunogenomics market, by end user, 2021 - 2033 (USD million)
Table 91 Latin America immunogenomics market, by country, 2021 - 2033 (USD million)
Table 92 Latin America immunogenomics market, by product type, 2021 - 2033 (USD million)
Table 93 Latin America immunogenomics market, by technology, 2021 - 2033 (USD million)
Table 94 Latin America immunogenomics market, by application, 2021 - 2033 (USD million)
Table 95 Latin America immunogenomics market, by end user, 2021 - 2033 (USD million)
Table 96 Brazil immunogenomics market, by product type, 2021 - 2033 (USD million)
Table 97 Brazil immunogenomics market, by technology, 2021 - 2033 (USD million)
Table 98 Brazil immunogenomics market, by application, 2021 - 2033 (USD million)
Table 99 Brazil immunogenomics market, by end user, 2021 - 2033 (USD million)
Table 100 Argentina immunogenomics market, by product type, 2021 - 2033 (USD million)
Table 101 Argentina immunogenomics market, by technology, 2021 - 2033 (USD million)
Table 102 Argentina immunogenomics market, by application, 2021 - 2033 (USD million)
Table 103 Argentina immunogenomics market, by end user, 2021 - 2033 (USD million)
Table 104 Middle East & Africa immunogenomics market, by country, 2021 - 2033 (USD million)
Table 105 Middle East & Africa immunogenomics market, by product type, 2021 - 2033 (USD million)
Table 106 Middle East & Africa immunogenomics market, by technology, 2021 - 2033 (USD million)
Table 107 Middle East & Africa immunogenomics market, by application, 2021 - 2033 (USD million)
Table 108 Middle East & Africa immunogenomics market, by end user, 2021 - 2033 (USD million)
Table 109 South Africa immunogenomics market, by product type, 2021 - 2033 (USD million)
Table 110 South Africa immunogenomics market, by technology, 2021 - 2033 (USD million)
Table 111 South Africa immunogenomics market, by application, 2021 - 2033 (USD million)
Table 112 South Africa immunogenomics market, by end user, 2021 - 2033 (USD million)
Table 113 Saudi Arabia immunogenomics market, by product type, 2021 - 2033 (USD million)
Table 114 Saudi Arabia immunogenomics market, by technology, 2021 - 2033 (USD million)
Table 115 Saudi Arabia immunogenomics market, by application, 2021 - 2033 (USD million)
Table 116 Saudi Arabia immunogenomics market, by end user, 2021 - 2033 (USD million)
Table 117 UAE immunogenomics market, by product type, 2021 - 2033 (USD million)
Table 118 UAE immunogenomics market, by technology, 2021 - 2033 (USD million)
Table 119 UAE immunogenomics market, by application, 2021 - 2033 (USD million)
Table 120 UAE immunogenomics market, by end user, 2021 - 2033 (USD million)
Table 121 Kuwait immunogenomics market, by product type, 2021 - 2033 (USD million)
Table 122 Kuwait immunogenomics market, by technology, 2021 - 2033 (USD million)
Table 123 Kuwait immunogenomics market, by application, 2021 - 2033 (USD million)
Table 124 Kuwait immunogenomics market, by end user, 2021 - 2033 (USD million)

List of Figures

Fig. 1 Immunogenomics market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Market formulation & validation
Fig. 7 Market outlook
Fig. 8 Segment snapshot
Fig. 9 Competitive landscape snapshot
Fig. 10 Parent market outlook
Fig. 11 Immunogenomics market driver analysis
Fig. 12 Immunogenomics market restraint analysis
Fig. 13 Immunogenomics market: Porter's analysis
Fig. 14 Immunogenomics market: PESTEL analysis
Fig. 15 Immunogenomics market: Product type outlook and key takeaways
Fig. 16 Immunogenomics market: Product type market share analysis, 2025 - 2033
Fig. 17 Global immunogenomics market by instruments market, 2021 - 2033 (USD Million)
Fig. 18 Global immunogenomics market by consumables market, 2021 - 2033 (USD Million)
Fig. 19 Global immunogenomics market by software market, 2021 - 2033 (USD Million)
Fig. 20 Immunogenomics market: Technology outlook and key takeaways
Fig. 21 Immunogenomics market: Technology market share analysis, 2025 - 2033
Fig. 22 Global immunogenomics market by next-generation sequencing (NGS) market, 2021 - 2033 (USD Million)
Fig. 23 Global immunogenomics market by polymerase chain reaction (PCR) market, 2021 - 2033 (USD Million)
Fig. 24 Global immunogenomics market by microarray market, 2021 - 2033 (USD Million)
Fig. 25 Global immunogenomics market by other technologies market, 2021 - 2033 (USD Million)
Fig. 26 Immunogenomics market: Application outlook and key takeaways
Fig. 27 Immunogenomics market: Application market share analysis, 2025 - 2033
Fig. 28 Global immunogenomics market by clinical applications market, 2021 - 2033 (USD Million)
Fig. 29 Global immunogenomics market by oncology / cancer immunotherapy market, 2021 - 2033 (USD Million)
Fig. 30 Global immunogenomics market by infectious diseases & vaccine research market, 2021 - 2033 (USD Million)
Fig. 31 Global immunogenomics market by autoimmune disorders market, 2021 - 2033 (USD Million)
Fig. 32 Global immunogenomics market by others market, 2021 - 2033 (USD Million)
Fig. 33 Global immunogenomics market by research applications market, 2021 - 2033 (USD Million)
Fig. 34 Immunogenomics market End user outlook and key takeaways
Fig. 35 Immunogenomics market: End user market share analysis, 2025 - 2033
Fig. 36 Global immunogenomics market by hospitals & diagnostic laboratories market, 2021 - 2033 (USD Million)
Fig. 37 Global immunogenomics market by academic & research institutes market, 2021 - 2033 (USD Million)
Fig. 38 Global immunogenomics market by pharmaceutical & Biotechnology Companies market, 2021 - 2033 (USD Million)
Fig. 39 Global immunogenomics market by other end users market, 2021 - 2033 (USD Million)
Fig. 40 Regional marketplace: Key takeaways
Fig. 41 North America immunogenomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 42 U.S. immunogenomics market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 43 Canada immunogenomics market, 2021 - 2033 (USD Million)
Fig. 44 Mexico immunogenomics market estimates and forecast, 2021 - 2033 (USD million)
Fig. 45 Europe immunogenomics market estimates and forecast, 2021 - 2033 (USD million)
Fig. 46 UK immunogenomics market estimates and forecast, 2021 - 2033 (USD million)
Fig. 47 Germany immunogenomics market estimates and forecast, 2021 - 2033 (USD million)
Fig. 48 France immunogenomics market estimates and forecast, 2021 - 2033 (USD million)
Fig. 49 Italy immunogenomics market estimates and forecast, 2021 - 2033 (USD million)
Fig. 50 Spain immunogenomics market estimates and forecast, 2021 - 2033 (USD million)
Fig. 51 Denmark immunogenomics market estimates and forecast, 2021 - 2033 (USD million)
Fig. 52 Sweden immunogenomics market estimates and forecast, 2021 - 2033 (USD million)
Fig. 53 Norway immunogenomics market estimates and forecast, 2021 - 2033 (USD million)
Fig. 54 Asia-Pacific immunogenomics market estimates and forecast, 2021 - 2033 (USD million)
Fig. 55 Japan immunogenomics market estimates and forecast, 2021 - 2033 (USD million)
Fig. 56 China immunogenomics market estimates and forecast, 2021 - 2033 (USD million)
Fig. 57 India immunogenomics market estimates and forecast, 2021 - 2033 (USD million)
Fig. 58 Australia immunogenomics market estimates and forecast, 2021 - 2033 (USD million)
Fig. 59 Thailand immunogenomics market estimates and forecast, 2021 - 2033 (USD million)
Fig. 60 South Korea immunogenomics market estimates and forecast, 2021 - 2033 (USD million)
Fig. 61 Latin America immunogenomics market estimates and forecast, 2021 - 2033 (USD million)
Fig. 62 Brazil immunogenomics market estimates and forecast, 2021 - 2033 (USD million)
Fig. 63 Argentina immunogenomics market estimates and forecast, 2021 - 2033 (USD million)
Fig. 64 MEA immunogenomics market estimates and forecast, 2021 - 2033 (USD million)
Fig. 65 South Africa immunogenomics market estimates and forecast, 2021 - 2033 (USD million)
Fig. 66 Saudi Arabia immunogenomics market estimates and forecast, 2021 - 2033 (USD million)
Fig. 67 UAE immunogenomics market estimates and forecast, 2021 - 2033 (USD million)
Fig. 68 Kuwait immunogenomics market estimates and forecast, 2021 - 2033 (USD million)